Delivery Order SPE2DB20D7059-SPE2DB24FQBB8
- Not listed
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a delivery order contract (SPE2DX15D3201|SPE2DX24F2W2T) by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract, valued at $1,048.50, is for the supply of XEOMIN 200 UNIT VIALS, a pharmaceutical product. The contract is a firm fixed price delivery order with a performance period through May 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,931.80 firm fixed price delivery order is for the supply of 100 unit vials of the pharmaceutical product XEOMIN. The contract has a performance period ending on July 2, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,145.50 to the Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This contract is for the delivery of 4564421570 units of XEOMIN 200 UNIT VIALS. The contract has a firm fixed price and an ultimate completion date of May 17, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the federal government, with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The award, valued at $7,339.50, is for the delivery of XEOMIN 200 unit vials, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price of $8,550.00 and a period of performance through March 29, 2024. It involves the supply of XEOMIN 50 unit vials, a pharmaceutical product, to DLA Troop Support Medical facilities supporting the Department of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, valued at $3,669.68 for the supply of 4,563,451,766 units of XEOMIN 100 unit vials. The delivery order is set to be completed by February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceutical products and medical supplies to the Department of Defense through an Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,048.48 firm fixed price delivery order is for the supply of 4563975341 XEOMIN 100 UNIT VIALS, with a period of performance through April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded Delivery Order SPE2DX15D1022|SPE2DX24FVEPP with a ceiling value of $88,074.00 to provide XEOMIN 200 unit vials to the Defense Logistics Agency (DLA) Troop Support Medical. This firm fixed price delivery order was awarded on March 11, 2024 with a performance period through April 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of XEOMIN 100 unit vials, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,621.20 and an ultimate completion date of May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of XEOMIN 100 unit vials. The contract, valued at $2,621.20, is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract has a firm fixed price and an ultimate completion date of May 16, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FQBB8Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $3,669.68 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide XEOMIN 200 UNIT VIALS. The award has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was not set aside. Amerisourcebergen Drug Corp is the prime contractor, with no major subcontractors identified.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 3/12/24 |